Adlerberth A, Jagenburg R, Lindstedt G, Stenström G, Hasselgren P O
Eur J Clin Invest. 1986 Aug;16(4):316-20. doi: 10.1111/j.1365-2362.1986.tb01348.x.
The aim of this investigation was to study the effect of beta-adrenoceptor blockade on alterations in protein metabolism induced by administration of 3,5,3'-triiodothyronine (T3) to man. Urinary excretion of 3-methylhistidine and plasma concentrations of amino acids were measured in seven healthy subjects following 1 weeks's administration of T3 alone or T3 in combination with the selective beta 1-adrenoceptor blocking agent metoprolol or the non-selective beta-adrenoceptor blocking agent propranolol. Urinary excretion of 3-methylhistidine and plasma concentrations of valine, methionine, lysine, tyrosine, phenylalanine, isoleucine, leucine, and total essential and branched chain amino acids increased following administration of T3, probably in part reflecting accelerated muscle proteolysis. Neither metoprolol nor propranolol normalized 3-methylhistidine excretion or plasma concentrations of amino acids during T3 treatment. The results indicate that metabolic alterations induced by T3 and giving rise to enhanced 3-methylhistidine excretion and elevated concentrations of plasma amino acids are not normalized by beta-adrenoceptor blockade.
本研究的目的是探讨β-肾上腺素能受体阻滞剂对人体服用3,5,3'-三碘甲状腺原氨酸(T3)后蛋白质代谢变化的影响。在7名健康受试者单独服用T3或T3联合选择性β1-肾上腺素能受体阻滞剂美托洛尔或非选择性β-肾上腺素能受体阻滞剂普萘洛尔1周后,测量其尿中3-甲基组氨酸的排泄量和血浆氨基酸浓度。服用T3后,尿中3-甲基组氨酸的排泄量以及血浆中缬氨酸、蛋氨酸、赖氨酸、酪氨酸、苯丙氨酸、异亮氨酸、亮氨酸以及必需氨基酸和支链氨基酸的总浓度均升高,这可能部分反映了肌肉蛋白水解加速。在T3治疗期间,美托洛尔和普萘洛尔均未使3-甲基组氨酸排泄量或血浆氨基酸浓度恢复正常。结果表明,T3诱导的导致3-甲基组氨酸排泄增加和血浆氨基酸浓度升高的代谢变化不能通过β-肾上腺素能受体阻滞恢复正常。